Home/Filings/4/0000899243-20-022554
4//SEC Filing

Deutsch Barry M. 4

Accession 0000899243-20-022554

CIK 0001346302other

Filed

Aug 16, 8:00 PM ET

Accepted

Aug 17, 3:45 PM ET

Size

6.2 KB

Accession

0000899243-20-022554

Insider Transaction Report

Form 4
Period: 2020-08-14
Deutsch Barry M.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-08-14+100,000100,000 total
    Exercise: $4.19Exp: 2030-08-14Common Stock (100,000 underlying)
Holdings
  • Common Stock

    93,090
Footnotes (1)
  • [F1]50% of these shares shall vest on the first anniversary of the vesting commencement date, 25% shall vest on the 18-month anniversary of the vesting commencement date and the remaining 25% shall vest on the second anniversary of the vesting commencement date.

Issuer

XERIS PHARMACEUTICALS INC

CIK 0001346302

Entity typeother

Related Parties

1
  • filerCIK 0001289407

Filing Metadata

Form type
4
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 3:45 PM ET
Size
6.2 KB